Despite the reports that have been released by the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure since 1977, increasing the percentage of Americans who know that they have hypertension and the numbers of those whose hypertension is being treated or controlled remains a tremendous challenge. Scores of drugs exist to treat hypertension — on which Americans spend billions of dollars each year, but billions more go toward costs associated with stroke, heart attack, and kidney disease stemming from undetected or inadequately treated hypertension.
In this context, a distinguished panel convened to discuss the scope of this health care crisis and the steps to to be taken to at long last address it effectively. Their deliberations are contained in this supplement.
JNC-7 and the New Therapeutic Approaches
Role of Fixed-Dose Combination Therapy
Economic Impact of Poor Diagnosis and Management
Roundtable Discussion: Effective Diagnosis, Management, and Treatment
Roundtable Discussion: Minimizing Costs and Maximizing Outcomes in the Real-World Setting